Overview

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
- To evaluate the effect of increasing the growth hormone dose on the statural response - To assess the value of early treatment during the course of arthritic disease by comparing the height acquired in the medium term by children in the two groups: treated from the start, or 1 year to 15 months after the diagnosis of CJA, or treated for 4 years after the diagnosis
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer